Heidi Harjunpää
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 2%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- T-cell and B-cell Immunology
Papers in
- Immunology 13
- Immunotherapy and Immune Responses 10
- Immune Cell Function and Interaction 6
- IL-33, ST2, and ILC Pathways 2
- Oncology 9
- Cancer Immunotherapy and Biomarkers 7
- Co-authors
- Camille Guillerey (4 shared papers)Susanna C. Fagerholm (7 shared papers)Carla Guenther (4 shared papers)Marc Llort Asens (3 shared papers)Mark J. Smyth (8 shared papers)Michele W.L. Teng (8 shared papers)Stacey Allen (6 shared papers)Kazuyoshi Takeda (5 shared papers)
In The Last Decade
Heidi Harjunpää
19 papers receiving 2.0k citations
Heidi Harjunpää's Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 1.3k
- Immunology 934
- Immunology and Allergy 80
- Cancer Research 195
- Pulmonary and Respiratory Medicine 393
Countries citing papers authored by Heidi Harjunpää
This map shows the geographic impact of Heidi Harjunpää's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Harjunpää with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Harjunpää more than expected).
Fields of papers citing papers by Heidi Harjunpää
This network shows the impact of papers produced by Heidi Harjunpää. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Harjunpää. The network helps show where Heidi Harjunpää may publish in the future.
Co-authors
The 25 scholars most cited alongside Heidi Harjunpää, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease Hit paper breakdown → | 2016 | 569 |
| 2 | Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment Hit paper breakdown → | 2019 | 511 |
| 3 | TIGIT as an emerging immune checkpoint Hit paper breakdown → | 2019 | 389 |
| 4 | 2018 | 222 | |
| 5 | 2016 | 76 | |
| 6 | 2018 | 69 | |
| 7 | 2017 | 68 | |
| 8 | 2018 | 37 | |
| 9 | 2019 | 23 | |
| 10 | 2008 | 17 | |
| 11 | 2021 | 15 | |
| 12 | 2017 | 15 | |
| 13 | 2012 | 15 | |
| 14 | 2018 | 13 | |
| 15 | 2020 | 8 | |
| 16 | 2024 | 6 | |
| 17 | 2024 | 1 | |
| 18 | 2016 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2025 | 0 |
About Heidi Harjunpää
Heidi Harjunpää is a scholar working on Immunology, Oncology, Molecular Biology, Immunology and Allergy and Plant Science, having authored 20 papers that have together received 2.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), Cancer Immunotherapy and Biomarkers (7 papers), Immune Cell Function and Interaction (6 papers), Cell Adhesion Molecules Research (5 papers), Plant Pathogenic Bacteria Studies (3 papers), Plant-Microbe Interactions and Immunity (2 papers), IL-33, ST2, and ILC Pathways (2 papers) and Melanoma and MAPK Pathways (2 papers). The work is most often cited by research in Oncology (1.3k citations), Immunology (934 citations), Immunology and Allergy (80 citations), Cancer Research (195 citations) and Pulmonary and Respiratory Medicine (393 citations). Heidi Harjunpää has collaborated with scholars based in Finland, Australia and Japan. Frequent co-authors include Camille Guillerey, Susanna C. Fagerholm, Carla Guenther, Marc Llort Asens, Mark J. Smyth, Michele W.L. Teng, Stacey Allen, Kazuyoshi Takeda, Stephen J. Blake and Jake S. O’Donnell. Their work appears in journals such as OncoImmunology, Frontiers in Immunology, Cancer Immunology Research, Blood and Molecular Plant-Microbe Interactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.